<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ruggiero T</submitter><funding>Telethon</funding><pagination>28</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC1858702</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8</volume><pubmed_abstract>BACKGROUND:KSRP is a AU-rich element (ARE) binding protein that causes decay of select sets of transcripts in different cell types. We have recently described that phosphatidylinositol 3-kinase/AKT (PI3K-AKT) activation induces stabilization and accumulation of the labile beta-catenin mRNA through an impairment of KSRP function. RESULTS:Aim of this study was to identify additional KSRP targets whose stability and steady-state levels are enhanced by PI3K-AKT activation. First, through microarray analyses of the AU-rich transcriptome in pituitary alphaT3-1 cells, we identified 34 ARE-containing transcripts upregulated in cells expressing a constitutively active form of AKT1. In parallel, by an affinity chromatography-based technique followed by microarray analyses, 12 mRNAs target of KSRP, additional to beta-catenin, were identified. Among them, seven mRNAs were upregulated in cells expressing activated AKT1. Both steady-state levels and stability of these new KSRP targets were consistently increased by either KSRP knock-down or PI3K-AKT activation. CONCLUSION:Our study identified a set of transcripts that are targets of KSRP and whose expression is increased by PI3K-AKT activation. These mRNAs encode RNA binding proteins, signaling molecules and a replication-independent histone. The increased expression of these gene products upon PI3K-AKT activation could play a role in the cellular events initiated by this signaling pathway.</pubmed_abstract><journal>BMC molecular biology</journal><pubmed_title>Identification of a set of KSRP target transcripts upregulated by PI3K-AKT signaling.</pubmed_title><pmcid>PMC1858702</pmcid><funding_grant_id>GGP04012</funding_grant_id><pubmed_authors>Khabar KS</pubmed_authors><pubmed_authors>Chen CY</pubmed_authors><pubmed_authors>Corte G</pubmed_authors><pubmed_authors>Ponassi M</pubmed_authors><pubmed_authors>Briata P</pubmed_authors><pubmed_authors>Ruggiero T</pubmed_authors><pubmed_authors>Trabucchi M</pubmed_authors><pubmed_authors>al-Haj L</pubmed_authors><pubmed_authors>Gherzi R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification of a set of KSRP target transcripts upregulated by PI3K-AKT signaling.</name><description>BACKGROUND:KSRP is a AU-rich element (ARE) binding protein that causes decay of select sets of transcripts in different cell types. We have recently described that phosphatidylinositol 3-kinase/AKT (PI3K-AKT) activation induces stabilization and accumulation of the labile beta-catenin mRNA through an impairment of KSRP function. RESULTS:Aim of this study was to identify additional KSRP targets whose stability and steady-state levels are enhanced by PI3K-AKT activation. First, through microarray analyses of the AU-rich transcriptome in pituitary alphaT3-1 cells, we identified 34 ARE-containing transcripts upregulated in cells expressing a constitutively active form of AKT1. In parallel, by an affinity chromatography-based technique followed by microarray analyses, 12 mRNAs target of KSRP, additional to beta-catenin, were identified. Among them, seven mRNAs were upregulated in cells expressing activated AKT1. Both steady-state levels and stability of these new KSRP targets were consistently increased by either KSRP knock-down or PI3K-AKT activation. CONCLUSION:Our study identified a set of transcripts that are targets of KSRP and whose expression is increased by PI3K-AKT activation. These mRNAs encode RNA binding proteins, signaling molecules and a replication-independent histone. The increased expression of these gene products upon PI3K-AKT activation could play a role in the cellular events initiated by this signaling pathway.</description><dates><release>2007-01-01T00:00:00Z</release><publication>2007 Apr</publication><modification>2021-02-20T07:35:38Z</modification><creation>2019-03-27T02:03:52Z</creation></dates><accession>S-EPMC1858702</accession><cross_references><pubmed>17437629</pubmed><doi>10.1186/1471-2199-8-28</doi></cross_references></HashMap>